Acute Coronary Syndrome clinical trials
17 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- A Polypill for Acute Coronary Syndrome
- TeleheartCR vs. Clinic-Based Cardiac Rehabilitation After Acute Coronary Syndrome
- Positive Emotions Following Acute Cardiac Events
- Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
- Remote Smoking Cessation in Hospitalized Cardiac Patients
- CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)
- Focused Orticumab Research for Treating Inflammation in Coronary Arteries
- Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study
- Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial
- A Prospective Research Investigation of Ischemia Using MCG
- Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock
- AngelMed Guardian® System PMA Post Approval Study
- Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions
- Breaking Fasts Ahead of Cardiac Caths
- Simultaneous Measurement of EpicArdial and Microvascular ResisTance Via Angiographic FLOW Study
- Study to Determine the Clinical Significance of Intravascular OCT-NIRAF
- Fractional Flow Reserve and Instantaneous Free-wave Ratio Revascularization Strategies in Women
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Acute Coronary Syndrome” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.